Biosergen AB (publ) (STO:BIOSGN)

Sweden flag Sweden · Delayed Price · Currency is SEK
40.20
+0.20 (0.50%)
Jan 21, 2026, 3:20 PM CET
-22.69%
Market Cap93.93M
Revenue (ttm)n/a
Net Income (ttm)-30.59M
Shares Out2.35M
EPS (ttm)-8.83
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,513
Average Volume1,230
Open40.00
Previous Close40.00
Day's Range40.00 - 40.20
52-Week Range28.10 - 67.80
Beta0.29
RSI41.44
Earnings DateMar 31, 2026

About Biosergen AB

Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol BIOSGN
Full Company Profile

Financial Performance

Financial Statements